First direct comparison of platelet reactivity and thrombolytic status between Japanese and Western volunteers: Possible relationship to the "Japanese paradox"

被引:47
作者
Gorog, Diana A. [1 ]
Yamamoto, Junichiro [2 ]
Saraf, Smriti
Ishii, Hiromitsu [3 ]
Ijiri, Yoshinobu [4 ]
Ikarugi, Hideo [5 ]
Wellsted, David M. [6 ]
Mori, Mari [7 ]
Yamori, Yukio [7 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, London, England
[2] Kobe Gakuin Univ, Physiol Lab, Kobe, Hyogo 65121, Japan
[3] Ishii Hosp, Akashi, Hyogo, Japan
[4] Hyogo Univ, Fac Hlth Sci, Dept Nutr Management, Kakogawa, Japan
[5] Univ Hyogo, Lab Hlth & Sport Sci, Kobe, Hyogo 6500044, Japan
[6] Univ Hertfordshire, Hlth Res & Dev Support Unit, Hatfield AL10 9AB, Herts, England
[7] Mukogawa Womens Univ, Inst World Hlth Dev, Nishinomiya, Hyogo, Japan
关键词
Thrombosis; Thrombolysis; Cardiovascular; Race; CORONARY-HEART-DISEASE; TISSUE-PLASMINOGEN-ACTIVATOR; ACUTE MYOCARDIAL-INFARCTION; PLASMA-FIBRINOGEN; RISK-FACTORS; CARDIOVASCULAR-DISEASE; CAUCASIAN MEN; UNITED-STATES; STROKE; INHIBITOR-1;
D O I
10.1016/j.ijcard.2010.07.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To determine and compare thrombotic and endogenous thrombolytic status in Japanese and Western populations. Background: Incidence of coronary heart disease (CHD) and AMI in Japan remains lower than in Western countries. Primary genetic effects are unlikely, given the increased CHD in Japanese migrants. For men, cholesterol and blood pressure have been similar in Japan and the U.S. Dietary factors are implicated, but how these effect CHD is unclear. We postulated that differences in thrombotic and/or thrombolytic status may contribute. Methods: We measured thrombotic and thrombolytic status in 100 healthy Japanese (J) from Japan and 100 healthy Westerners (W) from the U.K. using the Global Thrombosis Test (GTT). The GTT employs non-anticoagulated blood to create platelet-rich thrombi under high shear (occlusion time OT: seconds), and then measures the restart of blood flow, due to spontaneous thrombolysis (lysis time LT; seconds). Results: OT was longer in (J) compared to (W) (545 vs. 364, p<0.0001). LT was longer in (J) than in (W) (1753 vs. 1052, p<0.0001). Distribution of LT in (J) did not conform to a normal population, with markedly impaired thrombolytic status (LT>3000 s) in 18%, compared to none of the Westerners (p<0.0001). Conclusions: There are marked differences in thrombotic and thrombolytic status, with (J) having less prothrombotic (longer OT) but less favourable endogenous thrombolytic profile (longer LT). This may be important in the aetiology of thrombotic events. Since platelets and thrombolysis were both inhibited in (J) and yet incidence of AMI is lower, OT would seem more important than LT as a determinant of overall thrombotic risk in this population. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:43 / 48
页数:6
相关论文
共 51 条
[1]   Endogenous Thrombolysis A Hidden Player in Acute Coronary Syndromes? [J].
Barrabes, Jose A. ;
Galian, Laura .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (19) :2116-2117
[2]  
CHANDLER WL, 1990, BLOOD, V76, P930
[3]   Ethical authorship and publishing [J].
Coats, Andrew J. S. .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2009, 131 (02) :149-150
[4]   Haematocrit, viscosity, erythrocyte sedimentation rate: meta-analyses of prospective studies of coronary heart disease [J].
Danesh, J ;
Collins, R ;
Peto, R ;
Lowe, GDO .
EUROPEAN HEART JOURNAL, 2000, 21 (07) :515-520
[5]   Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease - Meta-analyses of prospective studies [J].
Danesh, J ;
Collins, R ;
Appleby, P ;
Peto, R .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (18) :1477-1482
[6]  
Egusa Genshi, 2004, J Atheroscler Thromb, V11, P304
[7]   Prognostic Value of Plasma Fibrinolysis Activation Markers in Cardiovascular Disease [J].
Gorog, Diana A. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (24) :2701-2709
[8]   Antiplatelet drug 'resistance'. Part 2: laboratory resistance to antiplatelet drugs-fact or artifact? [J].
Gorog, Diana A. ;
Sweeny, Joseph M. ;
Fuster, Valentin .
NATURE REVIEWS CARDIOLOGY, 2009, 6 (05) :365-373
[9]   Stroke in Japanese [J].
Hachinski, V .
STROKE, 2006, 37 (05) :1143-1143
[10]  
HAMSTEN A, 1987, LANCET, V2, P3